The global life sciences and health care company did not explain why it is closing the facility. The post Labcorp is closing ...

The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.

A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality ResultsSAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing ...

Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...

Labcorp Holdings Inc. LH, or Labcorp, is well-poised to grow in the coming quarters due to its strong, consistent performance in high-growth areas. In recent years, the company has built a significant ...

Labcorp has launched an offering that combines its diagnostic tests with a phlebotomy service from Getlabs to test consumers in their own homes. Earlier in the year, Getlabs announced its Series A ...